Cargando…

Clinical significance of plasma globotriaosylsphingosine levels in Chinese patients with Fabry disease

Although plasma globotriaosylsphingosine (lyso-Gb3) is a promising biomarker of Fabry disease (FD), few studies have assessed the impact of lyso-Gb3 in patients with FD. A total of 38 patients diagnosed with FD at Ruijin Hospital between January 2012 and December 2014 were recruited in the current s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouyang, Yan, Chen, Bing, Pan, Xiaoxia, Wang, Zhaohui, Ren, Hong, Xu, Yaowen, Ni, Liyan, Yu, Xialian, Yang, Li, Chen, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858121/ https://www.ncbi.nlm.nih.gov/pubmed/29563981 http://dx.doi.org/10.3892/etm.2018.5889

Ejemplares similares

Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
por: Tsukimura, Takahiro, et al.
Publicado: (2014)

Genotype: A Crucial but Not Unique Factor Affecting the Clinical Phenotypes in Fabry Disease
por: Pan, Xiaoxia, et al.
Publicado: (2016)

A new mutation found in newborn screening for Fabry disease evaluated by plasma globotriaosylsphingosine levels
por: Chinen, Yasutsugu, et al.
Publicado: (2017)

Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb(3)) in Fabry Transgenic Mice and in the Plasma of Fabry Patients
por: Young-Gqamana, Brandy, et al.
Publicado: (2013)

Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease
por: Jang, Heejoon, et al.
Publicado: (2019)

Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy
por: Franzen, Daniel, et al.
Publicado: (2018)

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
por: Tsukimura, Takahiro, et al.
Publicado: (2021)

Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease
por: Taguchi, Atsumi, et al.
Publicado: (2023)

Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
por: Namdar, Mehdi, et al.
Publicado: (2012)

Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort
por: Maruyama, Hiroki, et al.
Publicado: (2021)

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015)

Analysis of Lyso-Globotriaosylsphingosine in Dried Blood Spots
por: Johnson, Britt, et al.
Publicado: (2013)

A Rapid and Simple UHPLC-MS/MS Method for Quantification of Plasma Globotriaosylsphingosine (lyso-Gb3)
por: Perrone, Alessandro, et al.
Publicado: (2021)

Mass Spectrometry Analysis of Globotriaosylsphingosine and Its Analogues in Dried Blood Spots
por: Boutin, Michel, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide
por: Jeon, Yeo Jin, et al.
Publicado: (2015)

Lyso-globotriaosylsphingosine induces endothelial dysfunction via autophagy-dependent regulation of necroptosis
por: Hwang, Ae-Rang, et al.
Publicado: (2023)

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)
por: Liu, Hao-Chuan, et al.
Publicado: (2014)

A new multiplex analysis of glucosylsphingosine and globotriaosylsphingosine in dried blood spots by tandem mass spectrometry
por: Van Baelen, Amber, et al.
Publicado: (2023)

Transthyretin-related hereditary amyloidosis with recurrent vomiting and renal insufficiency as the initial presentation: A case report
por: Xu, Jing, et al.
Publicado: (2017)

Nephrogenic hypophosphatemic osteomalacia during adefovir monotherapy for chronic hepatitis B monoinfection
por: Xu, Yaowen, et al.
Publicado: (2013)

New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease
por: Weng, Qinjie, et al.
Publicado: (2020)

Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification
por: Chang, Hao‐Chih, et al.
Publicado: (2022)

Fabry disease with acute cerebral infarction onset in a young patient
por: Zhang, Ya-Nan, et al.
Publicado: (2019)

Paediatric Fabry disease: prognostic significance of ocular changes for disease severity
por: Kalkum, Gisela, et al.
Publicado: (2016)

New risk score for predicting progression of membranous nephropathy
por: Xiaofan, Hu, et al.
Publicado: (2019)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

High-Temperature Sensor Based on Fabry-Perot Interferometer in Microfiber Tip
por: Chen, Zhenshi, et al.
Publicado: (2018)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
por: Graziani, Francesca, et al.
Publicado: (2020)

A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD
por: Xie, Danshu, et al.
Publicado: (2019)

Basilar artery diameter as neuroimaging biomarker in Chinese Fabry disease patients
por: Lam, Yan Lok Tiffany, et al.
Publicado: (2023)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Fabry Cardiomyopathy
por: Yoon, Jae Yong, et al.
Publicado: (2013)

Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)
por: Lin, Hsiang-Yu, et al.
Publicado: (2013)

Improvement of gastrointestinal symptoms in a significant proportion of male patients with classic Fabry disease treated with agalsidase beta: A Fabry Registry analysis stratified by phenotype
por: Hopkin, Robert J., et al.
Publicado: (2020)

A graphene-based Fabry-Pérot spectrometer in mid-infrared region
por: Wang, Xiaosai, et al.
Publicado: (2016)

Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment
por: Yazdanfard, Puriya Daniel, et al.
Publicado: (2019)

Fabry disease: Mechanism and therapeutics strategies
por: Li, Xi, et al.
Publicado: (2022)

Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy
por: Heo, Sun Hee, et al.
Publicado: (2017)

Fibrinogen A Alpha-Chain Amyloidosis Associated With a Novel Variant in a Chinese Family
por: Jin, Shi, et al.
Publicado: (2021)

Simultaneous Measurement of Temperature and Pressure Based on Fabry-Perot Interferometry for Marine Monitoring
por: Zhang, Shengqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bevmhq2m879mvdio3qmngcopce